Executive Profile

Bennett M. Shapiro M.D. Senior Partner and Chairman, PureTech Ventures

Age	Total Calculated Compensation	This person is connected to 10 Board Members in 10 different organizations across 14 different industries. See Board Relationships
72	--

Background

Dr. Bennett M. Shapiro, Ben, M.D. is a Senior Advisor at Gelesis, Inc. Dr. Shapiro is a Senior Partner and Chairman of PureTech Ventures. He served as the Executive Vice President of Basic and External Research for Merck. He served as an Executive Vice President Of Basic And External Research, Worldwide at Merck & Co. Inc. He served as Medical & Scientific Advisor at Mersana Therapeutics, Inc. Dr. Shapiro joined Merck Research Laboratories in September 1990. In this ... position he was responsible for all the basic and preclinical research activities at Merck worldwide. He serves as Chairman of Vascular Biogenics Ltd. From 1999 to 2003 Dr. Shapiro oversaw all in-licensing activities for Merck. Previously, Dr. Shapiro led the research program that resulted in FDA registration of approximately 20 drugs and vaccines including Vioxx, Arcoxia, Emend, Cozaar, VACQTA, and many others. He serves as a Director of Celera Group. Dr. Shapiro has been an Independent Director of Momenta Pharmaceuticals Inc. since May 2003. He serves as Member of Scientific Advisory Board at Kala Pharmaceuticals, Inc. He has been a Director of Celera Corporation since May 2008. He serves as a Director of Satori Pharmaceuticals, and Protein Forest Inc. He serves as Scientific Advisor of RDAB Board at BG Medicine, Inc. and Fate Therapeutics, Inc. He serves as Director of Enlight Biosciences LLC and served as its Member of Advisory Board. Dr. Shapiro served as a Director at Ikaria Inc. since April 2005. He has served on many institutional advisory boards and scientific review panels. He served as a Director of Elixir Pharmaceuticals, Inc. since April 2003. He serves on the Harvard-MIT Division of Health Sciences and Technology Advisory Committee. He also sits on the boards of the Drugs for Neglected Disease Initiative and the Mind and Life Institute. He was a Professor and Chairman of the Department of Biochemistry at the University of Washington. Dr. Shapiro is the author of over 120 papers on the molecular regulation of cellular behavior and the biochemical events that integrate the cascade of cellular activations at fertilization. He holds Doctorate in Medicine from Thomas Jefferson University; M.D. from Thomas Jefferson University; and a B.S. in Chemistry from Dickinson College.

Corporate Headquarters 500 Boylston Street Boston, Massachusetts 02116 United States Phone: 617-482-2333 Fax: 617-482-3337 Board Members Memberships Chairman Vascular Biogenics Ltd. Director Protein Forest, Inc. Senior Partner and Chairman PureTech Ventures Director Satori Pharmaceuticals Incorporated Director Enlight Biosciences LLC 2003-N/A Former Director Elixir Pharmaceuticals, Inc. 2003-Present Independent Director, Chairman of Science Committee and Member of Compensation Committee Momenta Pharmaceuticals Inc. 2005-N/A Former Director and Member of Compensation Committee Ikaria, Inc. 2008-Present Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee Celera Corporation Education Doctorate Thomas Jefferson University MD Thomas Jefferson University BS Dickinson College Other Affiliations Merck & Co. Inc. Celera Corporation BG Medicine, Inc. Mersana Therapeutics, Inc. Elixir Pharmaceuticals, Inc. Thomas Jefferson University Dickinson College Vascular Biogenics Ltd. Momenta Pharmaceuticals Inc. Protein Forest, Inc. Ikaria, Inc. Gelesis, Inc. Satori Pharmaceuticals Incorporated Enlight Biosciences LLC Fate Therapeutics, Inc. Kala Pharmaceuticals, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.